Abstract: An integrated circuit (IC) package includes an IC chip, a package carrier, and a plurality of conductive bumps connecting the IC chip to the package carrier. The IC chip includes a substrate and an IC layered structure configured on an active surface of the substrate. The active surface has a core area and a signal area surrounding the core area. The IC layered structure includes a first physical layer interface. The first physical layer interface includes a plurality of first bump pads and a plurality of first inner pads electrically connected to the first bump pads, respectively. The first inner pads are arranged in multiple rows in the signal area.

Abstract: C-aryl glucoside derivatives, preparation processes and pharmaceutical uses thereof are disclosed. In particular, C-aryl glucoside derivatives represented by formula (I), with each substituent defined in the application, pharmaceutically acceptable salts or stereoisomers thereof, their preparation methods, and pharmaceutical compositions containing the derivatives as well as their uses as therapeutic agents, particularly as sodium-dependent glucose cotransporter (SGLT)-1 inhibitors, are disclosed.

Abstract: Pharmaceutically acceptable salts of (R)-7-[3-amino-4-(2,4,5-trifluorophenyl)-butyryl]-3-trifluoromethyl-5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine-1-formic acid, their preparation methods, compositions containing the said pharmaceutical salts and their use as medicaments, especially as dipeptidyl peptidase IV (DPP-IV) inhibitors are disclosed. Of the many acceptable salts, one example is the following.

Abstract: Tetrahydro-imidazo[1,5-a]pyrazine derivatives of formula (I), their preparation methods, pharmaceutical compositions containing the derivatives and uses thereof as medicaments, especially as dipeptidyl peptidase IV inhibitors, wherein the substituents of formula (I) are defined as same as the description.

Abstract: C-aryl glucoside derivatives, preparation processes and pharmaceutical uses thereof are disclosed. In particular, C-aryl glucoside derivatives represented by formula (I), with each substituent defined in the application, pharmaceutically acceptable salts or stereoisomers thereof, their preparation methods, and pharmaceutical compositions containing the derivatives as well as their uses as therapeutic agents, particularly as sodium-dependent glucose cotransporter (SGLT)-1 inhibitors, are disclosed.

Abstract: An illumination device includes a light tube holder including two connectors for receiving either a light-emitting diode (LED) tube or a fluorescent tube. One of the connectors includes a rotary member rotatably received in a through hole defined in a retainer, and three conductive elastic pieces positioned in the retainer around the through hole. One conductive piece is electrically connected to an LED tube drive circuit board and a fluorescent tube drive circuit board, and the other two conductive pieces are electrically connected to the LED and fluorescent tube drive circuit boards, respectively. The rotary member can be rotated to first and second positions, wherein at the first position, the LED tube can be activated, and at the second position the fluorescent tube can be activated.

Abstract: An illumination device includes a light tube holder including two connectors for receiving either a light-emitting diode (LED) tube or a fluorescent tube. One of the connectors includes a rotary member rotatably received in a through hole defined in a retainer, and three conductive elastic pieces positioned in the retainer around the through hole. One conductive piece is electrically connected to an LED tube drive circuit board and a fluorescent tube drive circuit board, and the other two conductive pieces are electrically connected to the LED and fluorescent tube drive circuit boards, respectively. The rotary member can be rotated to first and second positions, wherein at the first position, the LED tube can be activated, and at the second position the fluorescent tube can be activated.

Abstract: Provided herein are electroactive agglomerated particles, which comprise nanoparticles of a first electroactive material and nanoparticles of a second electroactive materials, and processes of preparation thereof.

Abstract: Tetrahydro-imidazo[1,5-a]pyrazine derivatives of formula (I), their preparation methods, pharmaceutical compositions containing the derivatives and uses thereof as medicaments, especially as dipeptidyl peptidase IV inhibitors, wherein the substituents of formula (I) are defined as same as the description.

Abstract: A multiple-input multiple-output (MIMO) device includes a substrate, a shielding cover and a MIMO antenna. The shielding cover is positioned on the substrate, and includes a plurality of sidewalls. The MIMO antenna includes a first solid antenna, a second solid antenna, and a plane antenna. The first solid antenna and the second solid antenna are electrically connected to two ends of one sidewall of the shielding cover, respectively. The first plane antenna is configured on the substrate, and disposed between the first solid antenna and the second solid antenna.

Abstract: Tetrahydro-imidazo[1,5-a]pyrazine derivatives of formula (I), their preparation methods, pharmaceutical compositions containing the derivatives and uses thereof as medicaments, especially as dipeptidyl peptidase IV inhibitors, wherein the substituents of formula (I) are defined as same as the description.

Abstract: Provided herein are electroactive agglomerated particles, which comprise nanoparticles of a first electroactive material and nanoparticles of a second electroactive materials, and processes of preparation thereof.

Abstract: Provided herein is a coated electroactive particle, comprising i) an electroactive agglomerated particle that comprises a first and second electroactive materials; and ii) a polymeric overcoating on the surface of the electroactive agglomerated particle. Also provided herein is a coated electroactive particle, comprising i) an agglomerated particle that comprises subparticles of a first electroactive material and subparticles of a second electroactive material; and ii) a polymeric overcoating on the surface of the electroactive agglomerated particle.

Abstract: An integrated circuit (IC) package includes an IC chip, a package carrier, and a plurality of conductive bumps connecting the IC chip to the package carrier. The IC chip includes a substrate and an IC layered structure configured on an active surface of the substrate. The active surface has a core area and a signal area surrounding the core area. The IC layered structure includes a first physical layer interface. The first physical layer interface includes a plurality of first bump pads and a plurality of first inner pads electrically connected to the first bump pads, respectively. The first inner pads are arranged in multiple rows in the signal area.

Abstract: Pharmaceutically acceptable salts of (R)-7-[3-amino-4-(2,4,5-trifluorophenyl)-butyryl]-3-trifluoromethyl-5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine-1-formic acid, their preparation methods, compositions containing the said pharmaceutical salts and their use as medicaments, especially as dipeptidyl peptidase IV (DPP-IV) inhibitors are disclosed.

Abstract: Provided herein is a non-spherical electroactive agglomerated particle, comprising one or more electroactive materials and optionally a binder. Also provided herein is a coated non-spherical electroactive particle, comprising i) a non-spherical agglomerated particle, which comprises one or more electroactive materials and optionally a binder, and ii) a polymeric overcoating on the surface of the non-spherical agglomerated particle.

Abstract: A multiple-input multiple-output (MIMO) device includes a substrate, a shielding cover and a MIMO antenna. The shielding cover is positioned on the substrate, and includes a plurality of sidewalls. The MIMO antenna includes a first solid antenna, a second solid antenna, and a plane antenna. The first solid antenna and the second solid antenna are electrically connected to two ends of one sidewall of the shielding cover, respectively. The first plane antenna is configured on the substrate, and disposed between the first solid antenna and the second solid antenna.

Abstract: Tetrahydro-imidazo[1,5-a]pyrazine derivatives of formula (I), their preparation methods, pharmaceutical compositions containing the derivatives and uses thereof as medicaments, especially as dipeptidyl peptidase IV inhibitors, wherein the substituents of formula (I) are defined as same as the description.

Abstract: Provided herein is a battery enclosure which comprises a flexible tubular battery housing having a top and bottom open end, and a top and bottom end plug, wherein the top and bottom end plugs are attached to the top and bottom open ends of the tubular battery housing, respectively, thus forming a sealed battery enclosure for housing a battery cell.

Abstract: A method for bonding two glassy metal pieces, includes: (a) disposing the glassy metal pieces in an environment such that the surrounding of the glassy metal pieces is heated to a working temperature within a common supercooled liquid region of the glassy metal pieces; and (b) pressing one of the glassy metal pieces against the other of the glassy metal pieces under an elevated pressure while maintaining the working temperature for a suitable period of time so as to subject the glassy metal pieces to undergo solid state diffusion at an interface therebetween.